Achillion to Present at Two Upcoming Investor Conferences

Fri Nov 30, 2012 4:05pm EST

* Reuters is not responsible for the content in this press release.

NEW HAVEN, Conn., Nov. 30, 2012 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN) announced today that members of the senior management team will present at the following investor conferences during the month of December:

  • Deutsche Bank 2012 dbAccess BioFEST Conference on Monday, December 3, 2012 at 11:20 a.m. EST at the Four Seasons Hotel in Boston, MA;
     
  • Oppenheimer 23rd Annual Healthcare Conference on Thursday, December 13, 2012 at 2:10 p.m. EST at the Waldorf=Astoria in New York City, NY.

The live audio broadcasts and the subsequent archived webcasts of the Company's presentations will be available on the Company's website, http://www.achillion.com, under the "News Center" section. The audio recording will be archived for 30 days following the live presentation. Please connect to Achillion's website several minutes prior to the start of the presentation to ensure adequate time for any software downloads that may be necessary.

About Achillion Pharmaceuticals

Achillion is an innovative pharmaceutical company dedicated to bringing important new treatments to patients with infectious disease. Achillion's proven discovery and development teams have advanced multiple product candidates with novel mechanisms of action. Achillion is focused on solutions for the most challenging problems in infectious disease including HCV and resistant bacterial infections. For more information on Achillion Pharmaceuticals, please visit www.achillion.com or call 1-203-624-7000.

CONTACT: Company Contact:
         Glenn Schulman
         Achillion Pharmaceuticals, Inc.
         Tel. (203) 624-7000
         gschulman@achillion.com
         
         Investors:
         Mary Kay Fenton
         Achillion Pharmaceuticals, Inc.
         Tel. (203) 624-7000
         mfenton@achillion.com